Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021;99(1):62-64.
doi: 10.1159/000510650. Epub 2020 Oct 13.

Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass

Roman Groisberg  1 , Vivek Subbiah  2
Affiliations
Comment

Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass

Roman Groisberg et al. Oncology. 2021.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

R Groisberg – No relevant conflict of interest to declare.

Comment on

References

    1. Groisberg R, Roszik J, Conley A, Patel SR, Subbiah V. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope. Curr Oncol Rep. 2017. 2017/12/01/;19(12):78. - PubMed
    1. Groisberg R, Subbiah V. The big, the bad, and the exon 11: adjuvant imatinib for all gastro-intestinal stromal tumors or just the ugly? Transl Gastroenterol Hepatol. 2017;2:81–81. - PMC - PubMed
    1. Boichard A, Wagner MJ, Kurzrock R. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing. Genome Medicine. 2020. 2020/07/09;12(1):61. - PMC - PubMed
    1. Italiano A. Targeting epigenetics in sarcomas through EZH2 inhibition. Journal of Hematology & Oncology. 2020. 2020/04/07;13(1):33. - PMC - PubMed
    1. Carmagnani Pestana R, Groisberg R, Roszik J, Subbiah V. Precision Oncology in Sarcomas: Divide and Conquer. JCO Precision Oncology. 2019;3:1–16. - PMC - PubMed

MeSH terms

Substances